Mandate

Vinge advises Velvet Cichlid on its public offer for Sleep Cycle

December 19, 2022 Life Sciences & Health

Velvet Cichlid has announced a public offer to the shareholders of Sleep Cycle AB (publ). The offer values the shares of Sleep Cycle at approximately SEK 862 million.

The Vinge team includes Jesper Schönbeck, Erik Sjöman, Linnéa Sellström, William Kåge, Emma Brolund, Philip Moré and Petter Hellgren (Capital Markets and Public M&A), Louise Brorsson Salomon and Seyran Sahin (Banking and Finance).

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026